Comparison of Storage and Transportation Regulatory Policies of Drug Third-party Logistics in China
Objective:To compare the regulatory policies of various provinces on the storage and transportation of drug third-party logistics,and to put forward feasible suggestions for strengthening the supervision of drug third-party logistics.Methods:By searching the websites of the National Medical Products Administration and provincial medical products administration,the regulatory policies on drug third-party logistics storage and transportation were obtained,the policies of different provinces and the relevant provisions of the Good Supply Practic were compared and analyzed,and suggestions were put forward.Results:Through comparison,it was found that the policies of various provinces on storage and transportation mainly focused on the storage area,storage facilities and equipment,cold storage quantity and volume requirements,cold storage power supply guarantee,temperature and humidity monitoring system,storage management system,vehicle quantity and vehicle equipment,transportation vehicle management,special drug transportation,transportation management system and other aspects.However,there were some differences in the specific regulations of different provinces.Moreover,the policy documents of most provinces still had problems:storage management policies were not unified,storage areas were not clearly divided,storage facilities and equipment provisions were not specific,transport-related policies were not comprehensive,and provisions were not made to ensure the normal temperature environment during the transportation of normal temperature drugs.Conclusion:Drug regulatory authorities should strengthen the scientific supervision of drug third-party logistics,and establish a unified third-party logistics management system.Drug third-party logistics enterprises should strengthen the construction of infrastructure and equipment,and strive to improve their own storage and transportation level.All relevant parties should make joint efforts to promote the healthy and orderly development of the pharmaceutical third-party logistics industry.